Early Strut Coverage and Its Implications for Dual Antiplatelet Therapy

Optical coherence tomography (OCT)-guided drug-eluting stent implantation improves early strut coverage compared with angiography-guided angioplasty. No difference was observed in terms of strut coverage between permanent-polymer everolimus-eluting stents and bioresorbable-polymer biolimus-eluting stents.

Short-term dual antiplatelet therapy may be feasible in selected patients with early strut coverage.

 

This study sought to measure early strut coverage in patients receiving drug-eluting stents (DES) and to explore whether the degree of coverage could be used to determine the duration of dual antiplatelet therapy.

 

The study randomized 894 patients to receive permanent-polymer everolimus-eluting stents (Xience) or biodegradable-polymer biolimus-eluting stents (Nobori) and to OCT-guided or angiography-guided implantation using a 2-by-2 factorial design.


Read also: Predicting Coronary Angioplasty Benefits.


Early strut coverage was measured as the percentage of uncovered struts observed in a 3-month follow-up OCT examination.

 

The primary endpoint was the difference in strut coverage between stents and between OCT- and angiography-guided procedures.

 

The secondary endpoint was a composite of cardiac death, acute myocardial infarction, stent thrombosis, and major bleeding during the first year after the procedure in patients who had received only 3 months of dual antiplatelet therapy based on early strut coverage (≤6% uncovered struts) as observed in a 3-month follow-up OCT.


Read also: The Importance of Tibial Artery Patency in the Rechanneling of the Femoral Artery.


The mean percentage of uncovered struts at 3 months was 8.9% and 8.2% with everolimus-eluting stents and biolimus-eluting stents, respectively (p = 0.69), and it was lower in the OCT-guided group (7.5%) than in the angiography-guided group (9.9%; p = 0.009).

 

Early strut coverage was observed in 41.1% of all patients. At 1 year, the composite event rarely occurred in patients who received 3-month (0.3%) or 12-month (0.2%) dual antiplatelet therapy (p = 0.80).

 

Conclusion

OCT-guided angioplasty improves early strut coverage compared with angiography alone as a guide, and this difference is not altered between everolimus- and biolimus-eluting stents. Short-term dual antiplatelet therapy is feasible in patients with early strut coverage.

 

Original title: Early Strut Coverage in Patients Receiving Drug-Eluting Stents and Its Implications for Dual Antiplatelet Therapy: A Randomized Trial.

Reference: Seung-Yul Lee et al. J Am Coll Cardiol Img 2018, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...